ABSI
Price
$2.90
Change
+$0.10 (+3.57%)
Updated
Jan 17 closing price
Capitalization
333.08M
59 days until earnings call
VCEL
Price
$59.07
Change
+$2.72 (+4.83%)
Updated
Jan 17 closing price
Capitalization
2.92B
44 days until earnings call
Ad is loading...

ABSI vs VCEL

Header iconABSI vs VCEL Comparison
Open Charts ABSI vs VCELBanner chart's image
Absci
Price$2.90
Change+$0.10 (+3.57%)
Volume$2.52M
Capitalization333.08M
Vericel
Price$59.07
Change+$2.72 (+4.83%)
Volume$291.43K
Capitalization2.92B
ABSI vs VCEL Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. VCEL commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and VCEL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ABSI: $2.90 vs. VCEL: $59.07)
Brand notoriety: ABSI and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 66% vs. VCEL: 73%
Market capitalization -- ABSI: $333.08M vs. VCEL: $2.92B
ABSI [@Biotechnology] is valued at $333.08M. VCEL’s [@Biotechnology] market capitalization is $2.92B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, VCEL is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while VCEL’s TA Score has 3 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 3 bearish.
  • VCEL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ABSI is a better buy in the short-term than VCEL.

Price Growth

ABSI (@Biotechnology) experienced а +1.58% price change this week, while VCEL (@Biotechnology) price change was -0.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ABSI is expected to report earnings on May 20, 2025.

VCEL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($2.92B) has a higher market cap than ABSI($333M). ABSI YTD gains are higher at: 10.687 vs. VCEL (7.576). VCEL has higher annual earnings (EBITDA): 10.4M vs. ABSI (-83.27M). ABSI has more cash in the bank: 127M vs. VCEL (102M). ABSI has less debt than VCEL: ABSI (12M) vs VCEL (97.5M). VCEL has higher revenues than ABSI: VCEL (227M) vs ABSI (4.21M).
ABSIVCELABSI / VCEL
Capitalization333M2.92B11%
EBITDA-83.27M10.4M-801%
Gain YTD10.6877.576141%
P/E RatioN/A738.38-
Revenue4.21M227M2%
Total Cash127M102M125%
Total Debt12M97.5M12%
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
38
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSIVCEL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
78%
Momentum
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
78%
MACD
ODDS (%)
Bullish Trend 12 days ago
90%
Bullish Trend 12 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 12 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 12 days ago
79%
Advances
ODDS (%)
Bullish Trend 14 days ago
89%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 20 days ago
73%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
88%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
73%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPIAX63.100.62
+0.99%
Invesco S&P 500 Index A
BVEFX20.330.14
+0.69%
Becker Value Equity Retail
VEMIX27.720.17
+0.62%
Vanguard Emerging Mkts Stock Idx Instl
EPLMX21.500.10
+0.47%
NYLI Epoch U.S. Equity Yield SIMPLE Cl
RETTX28.78N/A
N/A
Russell Inv Global Real Estate Secs M

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with CRSP. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+3.57%
CRSP - ABSI
50%
Loosely correlated
+0.57%
BEAM - ABSI
50%
Loosely correlated
+0.17%
PRME - ABSI
49%
Loosely correlated
+0.70%
RXRX - ABSI
47%
Loosely correlated
+2.03%
KYMR - ABSI
47%
Loosely correlated
+0.79%
More

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+4.83%
VCYT - VCEL
52%
Loosely correlated
-1.27%
BEAM - VCEL
45%
Loosely correlated
+0.17%
ABSI - VCEL
39%
Loosely correlated
+3.57%
NUVB - VCEL
39%
Loosely correlated
-1.18%
AXON - VCEL
38%
Loosely correlated
+1.37%
More